The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A2A receptors in inflammation and injury: lessons learned from transgenic animals
Open accessAbstract
Adenosine regulates the function of the innate and adaptive immune systems through targeting virtually every cell type that is involved in orchestrating an immune/inflammatory response. Of the four adenosine receptors (A1, A2A, A2B, A3), A2A receptors have taken center stage as the primary anti-inflammatory effectors of extracellular adenosine. This broad, anti-inflammatory effect of A2A receptor activation is a result of the predominant expression of A2A receptors on monocytes/macrophages, dendritic cells, mast cells, neutrophils, endothelial cells, eosinophils, epithelial cells, as well as lymphocytes, NK cells, and NKT cells. A2A receptor activation inhibits early and late events occurring during an immune response, which include antigen presentation, costimulation, immune cell trafficking, immune cell proliferation, proinflammatory cytokine production, and cytotoxicity. In addition to limiting inflammation, A2A receptors participate in tissue remodeling and reparation. Consistent with their multifaceted, immunoregulatory action on immune cells, A2A receptors have been shown to impact the course of a wide spectrum of ischemic, autoimmune, infectious, and allergic diseases. Here, we review the regulatory roles of A2A receptors in immune/inflammatory diseases of various organs, including heart, lung, gut, liver, kidney, joints, and brain, as well as the role of A2A receptors in regulating multiple organ failure and sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431 · cited 1×
“Selective antagonists for the A2A receptor are also available, and they include ZM241385 (4-{2-[7amino-2-(2-furyl) (1, 2, 4)triazolo(2,3-a) (1, 3, 5)triazin-5-ylamino]ethyl}-phenol) and SCH 58621 {5-amino-7-(2phenylethyl)-2-(2-furyl)-pyrazolo[4,3-(ε)]-1,2,4-triazolo(1,5-c)pyrimidine [26]}.”
Method
Cited by
Pearce, E. J., & Everts, B. (2015) · Nature Reviews Immunology · doi:10.1038/nri3771 · Cited by 483
Adenosine Receptors: Expression, Function and Regulation
Sheth, S., Brito, R., Mukherjea, D., Rybak, L., & Ramkumar, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15022024 · Cited by 401
Staphylococcus aureus synthesizes adenosine to escape host immune responses
Thammavongsa, V., Kern, J. W., Missiakas, D. M., & Schneewind, O. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090097 · Cited by 252
Ruiz-García, A., Monsalve, E., Novellasdemunt, L., Navarro-Sabaté, À., Manzano, A., Rivero, S., Castrillo, A., Casado, M., Laborda, J., Bartrons, R., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190298 · Cited by 95
Kim, S. T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17081024 · Cited by 18
Metadata
- Authors
- Haskó, G., & Pacher, P.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-26
- Volume
- 83
- Issue
- 3
- Pages
- 447-455
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W1967412131
- Cited by
- 240
- References
- 1
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A2A receptors in inflammation and injury: lessons learned from transgenic animals. https://app.cochat.ai/papers/10.1189/jlb.0607359
- The paper
- Haskó, G., & Pacher, P. (2008). A2A receptors in inflammation and injury: lessons learned from transgenic animals. Journal of Leukocyte Biology. https://doi.org/10.1189/jlb.0607359
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.